Genetic predisposition for development of nephropathy in type 2 diabetes mellitus

Biochemical Genetics

Volumn 51, Issue 11-12, 2013, Pages 865-875

  Kumar, Ravindra ^a   Sharma, Raj Kumar ^a   Agarwal, Sarita ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Angiotensin converting enzyme gene polymorphism; Diabetic nephropathy; End stage renal disease; Methylenetetrahydrofolate reductase gene polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ACE GENE; ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MTHFR GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; LIPOPROTEINS, LDL; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; SMOKING; TRIGLYCERIDES;

EID: 84888354198     PISSN: 00062928     EISSN: 15734927     Source Type: Journal    
DOI: 10.1007/s10528-013-9613-x     Document Type: Article

References (51)

1. Arzu Ergen H, Hatemi H, Agachan B, Camlica H, Isbir T (2004) Angiotensin-I converting enzyme gene polymorphism in Turkish type 2 diabetic patients. Exp Mol Med 36:345-350
2. Berge KE, Bakken A, Bohn M, Erikssen J, Berg K (1997) A DNA polymorphism at the angiotensin II type I (ATIR) locus and myocardial infarction. Clin Genet 52:71-76
3. Bhavani BA, Padma T, Sastry BKS, Reddy NK, Nausheen K (2005) The insertion I/deletion D polymorphism of angiotensin-converting enzyme (ACE) gene increase the susceptibility to hypertension and/or diabetes. Int J Hum Genet 5(4):247-252
4. Blüthner M, Brüntgens A, Schmidt S, Strojek K, Grzeszczak W, Ritz E (1999) Association of methylenetetrahydrofolate reductase gene polymorphism and diabetic nephropathy in type 2 diabetes? Nephrol Dial Transpl 14:56-57
5. Böger CA, Stubanus M, Haak T, Götz AK, Christ J, Hoffmann U, Riegger GA, Krämer BK (2007) Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy. Nehprol Dial Transpl 22:154-162
6. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH (2001) Effect of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861-869
7. Cho EH, Kim EH, Kim WG, Jeong EH, Koh EH, Lee WJ, Kim MS, Park JY, Lee KU (2010) Homocysteine as a risk factor for development of microalbuminuria in type 2 diabetes. Korean Diabetes J 34:200-206
8. Chowdhury TA, Dyer PH, Kumar S, Barnett AH, Bain SC (1999) Genetic determinants of diabetic nephropathy. Clin Sci 96:221-230
9. Cui WP, Du B, Jia Y, Zhou WH, Liu SM, Cui YC, Ma FZ, Luo P, Miao LN (2012) Is C677T polymorphism in methylenetetrahydrofolate reductase gene a risk factor for diabetic nephropathy or diabetes mellitus in a Chinese population? Arch Med Res 43(1):42-50
10. Degirmenci I, Kebapci N, Basaran A, Efe B, Gunes HV, Akalin A, Kurt H, Urhan M, Demirustu C (2005) Frequency of angiotensin-converting enzyme gene polymorphism in Turkish type 2 diabetic patients. Int J Clin Pract 59:1137-1142
11. Eroglu Z, Erdogan M, Tetik A, Karadeniz M, Cetinalp S, Kosova B, Gunduz C, Ozgen AG, Yilmaz C (2007) The relationship of the methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy. Diabetes Metab Res Rev 23(8):621-624
12. Freedman BI, Tuttle AB, Spray BJ (1995) Familial predisposition to nephropathy in African-Americans with non-insulin dependent diabetes mellitus. Am J Kidney Dis 25:710-713
13. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, Rozen R (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113
14. Fujita H, Narita T, Meguro H, Ishii T, Hanyu O, Suzuki K, Kamoi K, Ito S (1999) No association between MTHFR gene polymorphism and diabetic nephropathy in Japanese type II diabetic patients with proliferative diabetic retinopathy. J Diabetes Complicat 13:284-287
15. Galati G, Gentilucci UV, Mazzarelli C, Gallo P, Grasso RF, Stellato L, Afeltra A, Picardi A (2011) Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations. Am J Med Sci 342:79-82
16. Grzeszczak W, Zychma MJ, Lacka B, Zukowska-Szczechowska E (1998) Angiotensin I-converting enzyme gene polymorphisms: relationship to nephropathy in patients with non-insulin dependent diabetes mellitus. J Am Soc Nephrol 9(9):1664-1669
17. Ha SK, Park HC, Park HS, Kang BS, Lee TH, Wang Y (2003) ACE gene polymorphism and progression of diabetic nephropathy in Korean type 2 diabetic patients: effect of ACE gene DD on the progression of diabetic nephropathy. Am J Kidney Dis 41:943-949
18. Hozyasz KK, Mostowska A, Szaflarska-Poplawska A, Lianeri M, Jagodzinski PP (2011) Polymorphic variants of genes involved in homocysteine metabolism in celiac disease. Mol Biol Rep 39:3123-3130
19. Jafari Y, Rahimi Z, Vaisi-Raygani A, Rezaei M (2011) Interaction of eNOS polymorphism with MTHFR variants increases the risk of diabetic nephropathy and its progression in type 2 diabetes mellitus patients. Mol Cell Biochem 353:23-24
20. Jeffers BW, Estacio RO, Raynolds MV, Schrier RW (1997) Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy. Kidney Int 52(2):473-477
21. Kumar A, Mohindru K, Sehajpal PK (2005) Angiotensin-I converting enzyme polymorphism and diabetic nephropathy in North India. Int J Hum Genet 5(4):279-283
22. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I, Collaborative Study Group (2001) Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. New Engl J Med 345:851-860
23. Maeda M, Yamamoto I, Fukuda M, Motomura T, Nishida M, Nonen S, Fujio Y, Kasayama S, Azuma J (2008) MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients. J Diabetes Complicat 22:119-125
24. Mataradzija A, Resić H, Rasić S, Kukavica N, Masnić F (2010) Risk factors for development of cardiovascular complications in patients with chronic renal disease and diabetic nephropathy. Bosn J Basic Med Sci 10(suppl 1):S44-S50
25. Moczulski D, Fojcik H, Zukowska-Szczechowska E, Szydlowska I, Grzeszczak W (2003) Effects of the C677T and A1298C polymorphisms of the MTHFR gene on the genetic predisposition for diabetic nephropathy. Nephrol Dial Transpl 18:1535-1540
26. Movva S, Alluri RV, Venkatasubramanian S, Vedicherla B, Vattam KK, Ahuja YR, Hasan Q (2011) Association of methylenetetrahydrofolate reductase C677T genotype with type 2 diabetes mellitus patients with and without renal complications. Genet Test Mol Biomarkers 15(4):257-261
27. Mtiraoui N, Ezzidi I, Chaieb M, Marmouche H, Aouni Z, Chaieb A, Mahjoub T, Vaxillaire M, Almawi WY (2007) MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients. Diabetes Res Clin Pract 75:99-106
28. Naresh VV, Reddy AL, Sivaramakrishna G, Sharma PV, Vardhan RV, Kumar VS (2009) Angiotensin-converting enzyme gene polymorphism in type II diabetics with nephropathy. Indian J Nephrol 19(4):145-148
29. Nemr R, Salman RA, Jawad LH, Juma EA, Keleshian SH, Almawi WY (2010) Differential contribution of MTHFR C677T variant to the risk of diabetic nephropathy in Lebanese and Bahraini Arabs. Clin Chem Lab Med 48:1091-1094
30. Nikzamir A, Esteghamati A, Feghhi M, Nakhjavani M, Rashidi A, Reza JZ (2009) The insertion/deletion polymorphism of the angiotensin-converting enzyme gene is associated with progression, but not development, of albuminuria in Iranian patients with type 2 diabetes. J Renin Angiotensin Aldosterone Syst 10(2):109-114
31. Odawara M, Yamashita K, Yamada N (1999) MTHFR gene variant is not associated with diabetic nephropathy in Japanese. Nucleic Acids Symp Ser 42:85-86
32. Park HC, Choi SR, Kim BS, Lee TH, Kang BS, Choi KH, Lee HY, Han DS, Ha SK (2005) Polymorphism of the ACE gene in dialysis patients: overexpression of DD genotype in type 2 diabetes end-stage failure patients. Yonesi Med J 46(6):779-787
33. Prasad P, Tiwari AK, Kumar KM, Ammini AC, Gupta A, Gupta R, Sharma AK, Rao AR, Nagendra R, Chandra TS, Tiwari SC, Rastogi P, Gupta BL, Thelma BK (2006) Chronic renal insufficiency among Asian Indians with type 2 diabetes: 1. Role of RAAS gene polymorphisms. BMC Med Genet 7:42-50
34. Rahimi M, Hasanvand A, Rahimi Z, Vaisi-Raygani A, Mozafari H, Rezaei M, Zargooshi J, Najafi F, Shakiba E (2010) Synergistic effects of the MTHFR C677T and A1298C polymorphisms on the increased risk of micro-and macro-albuminuria and progression of diabetic nephropathy among Iranians with type 2 diabetes mellitus. Clin Biochem 43:1333-1339
35. Rahimi Z, Felehgari V, Rahimi M, Mozafari H, Yari K, Vaisi-Raygani A, Rezaei M, Malek-Khosravi S, Khazaie H (2011) The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria. Mol Biol Rep 38:2117-2123
36. Rigat B, Hubert C, Alhene-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346
37. Rigat B, Hubert C, Corvol P, Soubrier F (1992) PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acid Res 20:1433
38. Schmidt S, Ritz E (1997) Angiotensin I-converting enzyme polymorphism and diabetic nephropathy in type II diabetes. Nephrol Dial Transpl 12(Suppl 2):37-41
39. Shin JS, Oh KS, Kwon SK, Ji JH, Lee TW, Park YS, Kim MS, Koong SS, Oh TG (2001) MTHFR gene polymorphism as a risk factor for diabetic nephropathy and macrovascular disease in NIDDM patient. Korean J Med 61(4):391-398
40. Shin Shin Y, Baek SH, Chang KY, Park CW, Yang CW, Jin DC, Kim YS, Chang YS, Bang BK (2004) Relations between eNOS Glu298Asp polymorphism and progression of diabetic nephropathy. Diabetes Res Clin Pract 65:257-265
41. Shpichinetsky V, Raz I, Friedlander Y, Goldschmidt N, Wexler ID, Ben-Yehuda A, Friedman G (2000) The association between two common mutations C677T and A1298C in human methylenetetrahydrofolate reductase gene and the risk for diabetic nephropathy in type II diabetic patients. J Nutr 130(10):2493-2497
42. Sun J, Xu Y, Zhu Y, Lu H (2004) Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients. Diabetes Res Clin Pract 64(3):185-190
43. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Parving HH (1995) Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 44:489-494
44. Ukinc K, Ersoz HO, Karahan C, Erem C, Eminagaoglu S, Hacihasanoglu AB, Yilmaz M, Kocak M (2009) Methyltetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia as a novel risk factor for diabetic nephropathy. Endocrine 36:255-261
45. Van Ittersum FJ, de Man AM, Thijssen S, de Knijff P, Slagboom E, Smulders Y, Tarnow L, Donker AJ, Bilo HJ, Stehouwer CD (2000) Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus. Nephrol Dial Transpl 15:1000-1007
46. Viswanathan V, Zhu Y, Bala K, Dunn S, Snehalatha C, Ramachandran A, Jayaraman M, Sharma K (2001) Association between ACE gene polymorphism and diabetic nephropathy in south Indian patients. J Pancreas 2:83-87
47. Wang F, Fang Q, Yu N, Zhao D, Zhang Y, Wang J, Wang Q, Zhou X, Cao X, Fan X (2012) Association between genetic polymorphism of the angiotensin-converting enzyme and diabetic nephropathy: a meta-analysis comprising 26,580 subjects. J Renin Angiotensin Aldosterone Syst 13(1):161-174
48. Wong TY, Chan JC, Poon E, Li PK (1999) Lack of association of angiotensin-converting enzyme (DD/II) and angiotensinogen M235T gene polymorphism with renal function among Chinese patients with type II diabetes. Am J Kidney Dis 33:1064-1070
49. Yoshida H, Kuriyama S, Atsumi Y, Tomonari H, Mitarai T, Hamaguchi A, Kubo H, Kawaguchi Y, Kon V, Matsuoka K, Ichikawa I, Sakai O (1996) Angiotensin I-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 50(2):657-664
50. Yoshioka K, Yoshida T, Takakura Y, Kogure A, Umekawa T, Toda H, Yoshikawa T (2003) No association between the MTHFR gene polymorphism and diabetic retinopathy in type 2 diabetic patients without overt nephropathy. Diabetes Care 26(6):1947-1948
51. Yoshioka K, Yoshida T, Umekawa T, Kogure A, Takakura Y, Toda H, Yoshikawa T (2004) Methylenetetrahydrofolate reductase gene polymorphism is not related to diabetic nephropathy in Japanese type 2 diabetic patients. Diabet Med 21:1051-1052